1.Bizarre Parosteal Osteochondromatous Proliferation in the Proximal Phalanx of the Third Toe: A Case Report.
Haeng Kee NOH ; Ho Seung JEON ; Seung Joo JEON ; Chan Sam MOON ; Seo Goo KANG ; Gyung Sub SONG
The Journal of the Korean Bone and Joint Tumor Society 2011;17(2):91-94
Bizarre parosteal osteochondromatous proliferation (BPOP) otherwise known as Nora's lesion, is a benign surface tumor of the small tubular bone of the hands and feet with high probability of local recurrence. The report of BPOP in the foot is very rare in our country. We report a case of BPOP of proximal phalanx of right 3rd toe in 44-year-old female, successfully managed by en-bloc marginal excision with a review of the literatures.
Adult
;
Female
;
Foot
;
Hand
;
Humans
;
Recurrence
;
Toes
2.The Immunogenicity of a Single Dose of Hepatitis A Virus Vaccines (Havrix(R) and Epaxal(R)) in Korean Young Adults.
Jiseun LIM ; Yeong Jun SONG ; Woong Sub PARK ; Haesook SOHN ; Moo Sik LEE ; Dong Hoon SHIN ; Chun Bae KIM ; Hwasung KIM ; Gyung Jae OH ; Moran KI
Yonsei Medical Journal 2014;55(1):126-131
PURPOSE: Assessing the immunogenicity of a single dose of hepatitis A virus (HAV) vaccines is important because some people receive only a single dose. However, previous studies have shown variable results and have not examined the effects of demographic characteristics other than gender. This study was performed to examine the immunogenicity of a single dose of HAV vaccine according to the vaccine type and demographic characteristics in young adults. MATERIALS AND METHODS: Seronegative medical school students were randomly allocated to receive either Havrix or Epaxal. RESULTS: After approximately 11 months, the seroconversion rate in 451 participants was 80.7%. In men, the Havrix group showed a significantly higher seroconversion rate (81.9%) than the Epaxal group (69.2%), whereas both vaccine groups showed similarly high immunogenicity in women (Havrix: 90.1%, Epaxal: 92.9%; P for interaction=0.062). According to the results of a multivariate analysis, Epaxal showed significantly lower immunogenicity than Havrix only in men. Age, obesity, drinking, smoking, and follow-up time did not significantly affect seroconversion in either gender. CONCLUSION: The seroconversion rate of single-dose HAV vaccines was low in men, particularly in those who received Epaxal. Our results suggest that gender effects should be considered when comparing the immunogenicity of different HAV vaccines.
Adolescent
;
Adult
;
Female
;
Hepatitis A/*immunology/*prevention & control
;
Hepatitis A Vaccines
;
Hepatitis A Virus, Human/*immunology/*pathogenicity
;
Humans
;
Male
;
Young Adult